Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

IRS-1 Regulation in Insulin Resistance
Molecular Regulation of Muscle Glucose Metabolism in Man, Protocol 4
Status: Enrolling
Updated:  2/17/2012
835
mi
from
Scottsdale, AZ
IRS-1 Regulation in Insulin Resistance
Molecular Regulation of Muscle Glucose Metabolism in Man, Protocol 4
Status: Enrolling
Updated: 2/17/2012
Mayo Clinic Arizona
835
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Status: Enrolling
Updated:  2/21/2012
1344
mi
from
New Haven, CT
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Continuous Glucose Monitoring in Critically Ill Surgical Patients
Status: Enrolling
Updated: 2/21/2012
Yale-New Haven Hospital
1344
mi
from
New Haven, CT
Click here to add this to my saved trials
Dance Dance Revolution (DDR) in Type 2 Diabetes
Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  2/24/2012
1171
mi
from
Los Angeles, CA
Dance Dance Revolution (DDR) in Type 2 Diabetes
Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 2/24/2012
Charles Drew University of Medicine and Science
1171
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
Status: Enrolling
Updated:  2/24/2012
572
mi
from
Bellaire, TX
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
Status: Enrolling
Updated: 2/24/2012
The University of Texas
572
mi
from
Bellaire, TX
Click here to add this to my saved trials
Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
A Phase 1, Open-Label, Single Cohort, Four-period Sequential Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated:  3/2/2012
570
mi
from
San Antonio, TX
Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine
A Phase 1, Open-Label, Single Cohort, Four-period Sequential Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated: 3/2/2012
Cetero Research
570
mi
from
San Antonio, TX
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
Status: Enrolling
Updated:  3/5/2012
1310
mi
from
Salinas, CA
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
Status: Enrolling
Updated: 3/5/2012
Diabetes Care Center
1310
mi
from
Salinas, CA
Click here to add this to my saved trials
Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
A Phase 1, Open-label, Single Cohort, Two-Period Fixed Sequence Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Twice Daily in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated:  3/6/2012
1321
mi
from
Miami, FL
Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg
A Phase 1, Open-label, Single Cohort, Two-Period Fixed Sequence Study to Assess the Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg Twice Daily in Subjects With Type 2 Diabetes Mellitus
Status: Archived
Updated: 3/6/2012
SeaView Research Inc.
1321
mi
from
Miami, FL
D Vitamin Intervention in VA
Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes
Status: Enrolling
Updated:  3/7/2012
608
mi
from
Chicago, IL
D Vitamin Intervention in VA
Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes
Status: Enrolling
Updated: 3/7/2012
Jesse Brown VA Medical Center, Chicago, IL
608
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study of Topical Human FGF-1 for Wound Healing
A Phase 1a, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Normal Volunteers Given Punch Skin Biopsies
Status: Enrolling
Updated:  3/9/2012
851
mi
from
Phoenix, AZ
Safety Study of Topical Human FGF-1 for Wound Healing
A Phase 1a, Open Label, Single Dose, Dose Response, Pilot Study to Evaluate the Safety and Tolerability of Human Fibroblast Growth Factor-1 (FGF-1) in Normal Volunteers Given Punch Skin Biopsies
Status: Enrolling
Updated: 3/9/2012
Dedicated Phase I
851
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Insulin Delivery Using Microneedles in Type 1 Diabetes
Insulin Delivery Using Microneedles in Type 1 Diabetes
Status: Enrolling
Updated:  3/19/2012
801
mi
from
Atlanta, GA
Insulin Delivery Using Microneedles in Type 1 Diabetes
Insulin Delivery Using Microneedles in Type 1 Diabetes
Status: Enrolling
Updated: 3/19/2012
Emroy University
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Insulin Secretion in Diabetes
Pathogenesis of the Impaired Incretin Effect in Type 2 Diabetes
Status: Enrolling
Updated:  3/20/2012
725
mi
from
Cincinnati, OH
Insulin Secretion in Diabetes
Pathogenesis of the Impaired Incretin Effect in Type 2 Diabetes
Status: Enrolling
Updated: 3/20/2012
VA Medical Center, Cincinnati
725
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Status: Enrolling
Updated:  3/21/2012
810
mi
from
Columbus, OH
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Glycemic Control and Variability for Congestive Heart Failure Exacerbation
Status: Enrolling
Updated: 3/21/2012
Ohio State University
810
mi
from
Columbus, OH
Click here to add this to my saved trials
810
mi
from
Columbus, OH
Ohio State University
810
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
846
mi
from
Tempe, AZ
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Agave Clinical Research
846
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
421
mi
from
Harrisburg, AR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Harrisburg Family Medical Center
421
mi
from
Harrisburg, AR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
372
mi
from
Little Rock, AR
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Arkansas Primary Care Clinic, P.A.
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1171
mi
from
San Fernando Valley, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Providence Clinical Research
1171
mi
from
San Fernando Valley, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1158
mi
from
Garden Grove, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Sc Clinical Research, Inc.
1158
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1167
mi
from
Lakewood, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Premiere Clinical Research
1167
mi
from
Lakewood, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1171
mi
from
Long Beach,, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Long Beach Center for Clinical Research
1171
mi
from
Long Beach,, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1168
mi
from
Los Angelas, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
UCLA Kidney Transplant Research
1168
mi
from
Los Angelas, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1168
mi
from
Los Angelas, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
David Geffen School of Medicine Division of Nephrology
1168
mi
from
Los Angelas, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1080
mi
from
Palm Springs, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Desert Oasis Healthcare Medical Group
1080
mi
from
Palm Springs, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1122
mi
from
Riverside, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Research of Riverside
1122
mi
from
Riverside, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1282
mi
from
Sacramento, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
River City Clinical Research
1282
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1240
mi
from
Santa Barbara, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Samsun Clinic
1240
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1152
mi
from
Tustin, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Orange County Research Center
1152
mi
from
Tustin, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1187
mi
from
West Hills, CA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Infosphere Clinical Research, Inc.
1187
mi
from
West Hills, CA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
407
mi
from
Denver, CO
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Creekside Endocrine Associates PC
407
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1314
mi
from
Hialeah, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Palm Spring Research Institute
1314
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1308
mi
from
Miami, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
San Marcus Research Clinic
1308
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1313
mi
from
Kendall Lakes-Lindgren Acres, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Advanced Pharma CR
1313
mi
from
Kendall Lakes-Lindgren Acres, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1126
mi
from
Ormond Beach, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Ormond Medical Arts Pharmaceutical Research
1126
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1147
mi
from
Winter Haven, FL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clincal Research of Central Florida
1147
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
776
mi
from
Blue Ridge, GA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
River Birch Research Alliance
776
mi
from
Blue Ridge, GA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
610
mi
from
Chicago, IL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Medical Research
610
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
609
mi
from
Chicago, IL
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
University of Chicago Medical Center
609
mi
from
Chicago, IL
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
630
mi
from
Avon, IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
American Health Network of IN
630
mi
from
Avon, IN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
663
mi
from
Greenfield, IN
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
American Healthcare Network of Indiana
663
mi
from
Greenfield, IN
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1130
mi
from
Hyattsville, MD
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Medstar Health Research Institute
1130
mi
from
Hyattsville, MD
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1444
mi
from
Boston, MA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Brigham and Women's Hosp
1444
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1444
mi
from
Boston, MA
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Harvard Medical School Beth Israel Deaconess Medical Center
1444
mi
from
Boston, MA
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
821
mi
from
Flint, MI
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Apex Medical Research, MI, Inc.
821
mi
from
Flint, MI
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
198
mi
from
Kansas City, MO
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Consultants (MO)
198
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1289
mi
from
, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
The Rogosin Institute
1289
mi
from
, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1300
mi
from
Rosedale, NY
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Development Associates (NY)
1300
mi
from
Rosedale, NY
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
1044
mi
from
Chapel Hill, NC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
University of North Carolina School of Medicine
1044
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
900
mi
from
Canton, OH
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Clinical Research Limited
900
mi
from
Canton, OH
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
176
mi
from
Norman, OK
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
Lynn Institute of Norman
176
mi
from
Norman, OK
Click here to add this to my saved trials
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated:  3/26/2012
947
mi
from
Aiken, SC
A Phase 2 Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients
A Phase 2, Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-499 in Type 2 Diabetic Nephropathy Patients Currently Treated With ACEI and/or ARB Therapy
Status: Enrolling
Updated: 3/26/2012
C.S.R.A. Renal Services
947
mi
from
Aiken, SC
Click here to add this to my saved trials